Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL91

MICONAZOLE
💊 Approved Drug
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
💊 Approved Drug
Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1

Basic Information

ChEMBL ID CHEMBL91
Name MICONAZOLE
Phase Approved
Structure Type MOL
InChI Key BYBLEWFAAKGYCD-UHFFFAOYSA-N
Therapeutic ✓ Yes

Known Names

Conofite Dermazole Dumicoat Loramyc Micatin Miconazol Miconazole Monistat Monistat-3 NSC-170986 Oravig Vusion
96
Targets
210
Activities
4
Assay Types
8
PK Parameters
20
Publications
12
Known Names
9
Indications
1
Mechanisms

Molecular Properties

416.1
MW (Da)
6.45
ALogP
3
HBA
0
HBD
27.1
PSA (Ų)
0.46
QED
1
Ro5 Violations
6
Rot. Bonds

Drug Information

Molecule Type Small molecule
First Approval 1974
Availability OTC
Chirality Racemic

Routes of Administration

Parenteral Topical

Flags

Natural Product
USAN Stem -conazole
USAN Year 1970

Extended Properties

Molecular Formula C18H14Cl4N2O
MW 416.13
Aromatic Rings 3
Heavy Atoms 25
NP-Likeness -0.92

Mechanism of Action

Mechanism Action Type Target Direct Efficacy
Cytochrome P450 51 inhibitor INHIBITOR Lanosterol 14-alpha demethylase

Indications

Infections Mycoses Pruritus Tinea Tinea Pedis HIV Infections Otomycosis Stomatitis Intertrigo

ATC Classification

A01AB09
miconazole
Level 1: ALIMENTARY TRACT AND METABOLISM
Level 2: STOMATOLOGICAL PREPARATIONS
A07AC01
miconazole
Level 1: ALIMENTARY TRACT AND METABOLISM
Level 2: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS
D01AC02
miconazole
Level 1: DERMATOLOGICALS
Level 2: ANTIFUNGALS FOR DERMATOLOGICAL USE
D01AC52
miconazole, combinations
Level 1: DERMATOLOGICALS
Level 2: ANTIFUNGALS FOR DERMATOLOGICAL USE
G01AF04
miconazole
Level 1: GENITO URINARY SYSTEM AND SEX HORMONES
Level 2: GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS
J02AB01
miconazole
Level 1: ANTIINFECTIVES FOR SYSTEMIC USE
Level 2: ANTIMYCOTICS FOR SYSTEMIC USE
S02AA13
miconazole
Level 1: SENSORY ORGANS
Level 2: OTOLOGICALS

Activity Summary

IC50 155 meas. best 10.7
Ki 48 meas. best 6.61
Kd 6 meas. best 7.14
EC50 1 meas. best 6.4

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Cytochrome P450 2C19
CHEMBL3622
IC50 10.7 7.042 0.0 5
Unchecked
CHEMBL612545
IC50 10.7 5.9415 0.0 20
Cytochrome P450 3A4
CHEMBL340
IC50 9.0 6.4309 1.0 11
Plasmodium yoelii yoelii
CHEMBL612328
IC50 8.69 8.69 2.0 1
Kluyveromyces marxianus
CHEMBL612842
IC50 7.52 7.52 30.0 1
Trypanosoma cruzi
CHEMBL368
IC50 7.4 7.4 40.0 1
Mycocyclosin synthase
CHEMBL1681615
Kd 7.14 7.14 73.0 1
Cytochrome P450 2C9
CHEMBL3397
IC50 6.94 6.02 115.0 3
Nakaseomyces glabratus
CHEMBL612647
IC50 6.92 6.92 120.0 1
Trichophyton rubrum
CHEMBL612649
IC50 6.85 6.665 140.0 2
Plasmodium falciparum
CHEMBL364
IC50 6.7 6.57 200.0 3
Lanosterol 14-alpha demethylase
CHEMBL3849
IC50 6.7 6.7 200.0 1
Sterol 14alpha-demethylase
CHEMBL5090
Kd 6.7 6.7 200.0 1
Microsporum canis
CHEMBL612335
IC50 6.64 6.64 230.0 1
Steroid 17-alpha-hydroxylase/17,20 lyase
CHEMBL3522
Ki 6.61 6.61 243.0 1
Thromboxane-A synthase
CHEMBL1835
IC50 6.58 6.58 263.0 1
Candida albicans
CHEMBL366
IC50 6.52 5.825 300.0 4
Aromatase
CHEMBL3859
EC50 6.4 6.4 400.0 1
Trichophyton mentagrophytes
CHEMBL613162
IC50 6.4 6.4 400.0 1
Sodium-dependent serotonin transporter
CHEMBL228
Ki 6.38 6.38 414.0 1
Muscarinic acetylcholine receptor M4
CHEMBL1821
Ki 6.35 6.35 446.0 1
Cytochrome P450 2J2
CHEMBL3491
IC50 6.24 6.215 580.0 2
Aromatase
CHEMBL1978
IC50 6.22 6.22 600.0 1
Muscarinic acetylcholine receptor M3
CHEMBL245
Ki 6.17 6.17 668.0 1
Sodium-dependent serotonin transporter
CHEMBL228
IC50 6.11 6.11 778.0 1
HL-60
CHEMBL383
IC50 6.1 6.1 800.0 1
Trichophyton quinckeanum
CHEMBL612334
IC50 6.1 6.1 790.0 1
Cytochrome P450 2D6
CHEMBL289
IC50 6.06 5.95 875.0 3
Unchecked
CHEMBL612545
Kd 6.03 5.7075 940.0 4
Muscarinic acetylcholine receptor M1
CHEMBL216
Ki 6.02 6.02 956.0 1
D(3) dopamine receptor
CHEMBL234
Ki 5.96 5.96 1086.0 1
5-hydroxytryptamine receptor 2A
CHEMBL224
Ki 5.95 5.95 1116.0 1
Delta-type opioid receptor
CHEMBL236
Ki 5.92 5.92 1194.0 1
Sodium-dependent dopamine transporter
CHEMBL238
Ki 5.87 5.87 1352.0 1
Indoleamine 2,3-dioxygenase 1
CHEMBL4685
IC50 5.85 5.495 1400.0 4
Pichia kudriavzevii
CHEMBL612841
IC50 5.85 5.85 1400.0 1
Alpha-2A adrenergic receptor
CHEMBL1867
Ki 5.83 5.83 1487.0 1
Alpha-1D adrenergic receptor
CHEMBL223
Ki 5.83 5.83 1497.0 1
7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase
CHEMBL4523494
IC50 5.82 5.82 1500.0 1
Muscarinic acetylcholine receptor M2
CHEMBL211
Ki 5.81 5.81 1542.0 1
Adenosine receptor A3
CHEMBL256
Ki 5.8 5.8 1589.0 1
Alpha-2B adrenergic receptor
CHEMBL1942
Ki 5.79 5.79 1642.0 1
Substance-K receptor
CHEMBL2327
Ki 5.79 5.79 1613.0 1
Sodium-dependent dopamine transporter
CHEMBL238
IC50 5.77 5.77 1701.0 1
Aspergillus fumigatus
CHEMBL363
IC50 5.72 5.72 1900.0 1
Progesterone receptor
CHEMBL1909044
Ki 5.71 5.71 1945.0 1
ATP-dependent translocase ABCB1
CHEMBL3467
IC50 5.7 5.7 2000.0 2
ATP-dependent translocase ABCB1
CHEMBL4302
IC50 5.7 5.54 2000.0 3
Unchecked
CHEMBL612545
Ki 5.69 5.372 2034.0 5
Acetylcholinesterase
CHEMBL4078
IC50 5.62 5.145 2400.0 2

Pharmacokinetic Data

Parameter Value Units Species
CL 660.1 mL.min-1.kg-1 Mus musculus
CL 660.0 mL.min-1.g-1 Mus musculus
T1/2 0.1383 hr Mus musculus
T1/2 0.1383 hr Mus musculus
T1/2 0.011 hr Mus musculus
T1/2 6.0 hr Mus musculus
T1/2 0.1383 hr Mus musculus
T1/2 6.0 hr Mus musculus

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
Cytochrome P450 2C19 IC50 = 0.02 nM 10.7 Inhibition of CYP2C19 in human liver Microsome using omeprazole as substrate in ... 36367749
Unchecked IC50 = 0.02 nM 10.7 Inhibition of CYP2C19 in rat liver Microsome using phenacetin as substrate in pr... 36367749
Unchecked IC50 = 0.02 nM 10.7 Inhibition of CYP2C19 in mouse liver Microsome using phenacetin as substrate in ... 36367749
Cytochrome P450 3A4 IC50 = 1.0 nM 9.0 Inhibition of CYP3A4 in human liver Microsome using midazolam as substrate in pr... 36367749
Unchecked IC50 = 1.0 nM 9.0 Inhibition of CYP3A4 in rat liver Microsome using phenacetin as substrate in pre... 36367749
Unchecked IC50 = 1.0 nM 9.0 Inhibition of CYP3A4 in mouse liver Microsome using phenacetin as substrate in p... 36367749
Plasmodium yoelii yoelii IC50 = 2.03 nM 8.69 Antimicrobial activity against Plasmodium yoelii 265 liver infected in mammalian... 18212104
Cytochrome P450 2C19 IC50 = 16.0 nM 7.8 DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin) -
Kluyveromyces marxianus IC50 = 30.0 nM 7.52 Antifungal activity against 5 x 10'6 CFU/ml Candida kefyr B46120 by resazurin ba... 20805398
Cytochrome P450 3A4 IC50 = 30.0 nM 7.52 Inhibition of CYP3A4 in human liver microsomes using midazolam as substrate prei... 37725043
Trypanosoma cruzi IC50 = 40.0 nM 7.4 DNDI: Chagas in Vitro, 96 hour -
Cytochrome P450 2C19 IC50 = 62.0 nM 7.21 Inhibition of CYP2C19 in human liver microsomes using diclofenac as substrate pr... 37725043
Mycocyclosin synthase Kd = 73.0 nM 7.14 Binding affinity to Mycobacterium tuberculosis H37Rv wild type CYP121 by titrati... 27002486
Cytochrome P450 3A4 IC50 = 74.2 nM 7.13 Inhibition of CYP3A4 in human liver microsome using Nifedipine as a substrate in... 34364163
Cytochrome P450 3A4 IC50 = 100.0 nM 7.0 DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluorome... -
Cytochrome P450 2C9 IC50 = 115.0 nM 6.94 Inhibition of CYP2C9 in human liver microsomes using diclofenac as substrate pre... 37725043
Nakaseomyces glabratus IC50 = 120.0 nM 6.92 Antifungal activity against 5 x 10'6 CFU/ml Candida glabrata B63155 by resazurin... 20805398
Trichophyton rubrum IC50 = 140.0 nM 6.85 Antifungal activity against 5 x 10'6 CFU/ml Trichophyton rubrum J941704 by resaz... 20805398
Cytochrome P450 3A4 IC50 = 180.0 nM 6.75 Inhibition of human cytochrome P450 3A4 12699389
Plasmodium falciparum IC50 = 200.0 nM 6.7 Antimalarial activity against chloroquine sensitive Plasmodium falciparum 33479627

Literature References

PubMed DOI Target Context # Activities
- 10.6019/CHEMBL3885881 Rattus norvegicus 725
357722 10.1021/jm00206a028 Candida albicans 26
29475581 10.1016/j.bmc.2018.02.014 Mus musculus 23
32403018 10.1016/j.ejmech.2020.112360 Unchecked 22
31191871 10.1039/C9MD00155G Candida albicans 20
33713977 10.1016/j.ejmech.2021.113337 Lanosterol 14-alpha demethylase 20
29602683 10.1016/j.bmcl.2018.03.022 Candida albicans 19
27128176 10.1016/j.ejmech.2016.04.020 Candida albicans 19
26965863 10.1016/j.bmcl.2016.03.002 Candida albicans 18
27089214 10.1016/j.ejmech.2016.03.042 Candida albicans 18
26646219 10.1016/j.bmcl.2015.11.063 Candida albicans 18
26586599 10.1016/j.bmcl.2015.10.086 Candida albicans 17
33333162 10.1016/j.bmcl.2020.127746 Candida albicans 15
22194678 10.1371/journal.pcbi.1002310 Hepatotoxicity 14
19015352 10.1128/aac.01095-08 Pichia kudriavzevii 13
33713977 10.1016/j.ejmech.2021.113337 Candida albicans 13
38116435 10.1021/acsmedchemlett.3c00406 Mycobacterium tuberculosis 11
27707604 10.1016/j.bmcl.2016.09.063 NON-PROTEIN TARGET 11
15646539 10.1016/s0399-8320(04)95062-2 Unchecked 11
32403018 10.1016/j.ejmech.2020.112360 Candida albicans 11

Data from ChEMBL 36 via Core Engine